期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
Insecticide resistance in Indian Anopheles: A stumbling block for malaria elimination 被引量:2
1
作者 nikhat khan Ashok Kumar Mishra Aparup Das 《Asian Pacific Journal of Tropical Medicine》 SCIE CAS 2020年第10期429-430,共2页
Malaria is a mosquito-borne disease caused by protozoan parasites of Plasmodium genus,inflicting health of human living in tropical and subtropical regions of the globe since time immemorial.
关键词 MALARIA PLASMODIUM INDIAN
下载PDF
Decline of Japanese encephalitis in Eastern Uttar Pradesh,India,2009-2019
2
作者 Neha Srivastava Hirawati Deval +2 位作者 nikhat khan Rajni Kant Aparup Das 《Asian Pacific Journal of Tropical Medicine》 SCIE CAS 2022年第5期230-231,共2页
Japanese encephalitis(JE),one of the major viral encephalitides,is caused by Flavivirus circulating in rural areas of Asia and Western Pacific regions[1]and is a neglected tropical viral disease due to its endemicity[... Japanese encephalitis(JE),one of the major viral encephalitides,is caused by Flavivirus circulating in rural areas of Asia and Western Pacific regions[1]and is a neglected tropical viral disease due to its endemicity[2].The culicine mosquitoes,mainly of Culex tritaeniorhynchus and Culex vishnui group,are the vectors of JE virus(JEV)[1].Being a neurologic infection,JE manifests with a set of serious symptoms leading to death in many cases and/or change in behaviour of the patients leading to permanent disability[3]. 展开更多
关键词 ENCEPHALITIS EASTERN NEGLECTED
下载PDF
Can the personalized medicine approach contribute in controlling tuberculosis in general and India in particular?
3
作者 nikhat khan Aparup Das 《Precision Clinical Medicine》 2020年第3期240-243,共4页
Poor drug compliance and drug-resistant Mycobacterium tuberculosis are the two principal obstacles in controlling tuberculosis(TB)in endemic regions including India,which has contributed the most to global TB burden.W... Poor drug compliance and drug-resistant Mycobacterium tuberculosis are the two principal obstacles in controlling tuberculosis(TB)in endemic regions including India,which has contributed the most to global TB burden.We argue here that a personalized medicine approach,to start with the N-acetyl transferase-2–isoniazid(NAT2–INH)model,could be a step forward in dealing with both these limitations in controlling TB in India. 展开更多
关键词 TUBERCULOSIS personalized medicine ISONIAZID N-acetyl transferase-2 INDIA
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部